Current Otorhinolaryngology Reports

, Volume 4, Issue 2, pp 142–147 | Cite as

Chronic Rhinosinusitis-Related Smell Loss: Medical and Surgical Treatment Efficacy

  • David A. Gudis
  • Zachary M. SolerEmail author
Taste and Smell Disorders (E Holbrook, Section Editor)
Part of the following topical collections:
  1. Taste and Smell Disorders


Chronic rhinosinusitis (CRS) is an inflammatory disorder of the nasal cavities and paranasal sinuses. Olfactory dysfunction is a common manifestation of CRS and one of its cardinal diagnostic features. A decreased sense of smell can have a profound impact on a CRS patient’s quality of life and overall wellbeing. The treatment of CRS-associated olfactory dysfunction includes a wide range of medical interventions, including anti-inflammatory and antibiotic medications, and surgical interventions, including endoscopic sinus and nasal surgery. The evidence and treatment efficacy for these interventions is quite varied. This review provides a summary of the efficacy of the medical and surgical therapeutic options for CRS-associated olfactory dysfunction.


Olfaction Smell loss Anosmia Chronic rhinosinusitis Olfactory dysfunction Endoscopic sinus surgery 


Compliance with Ethics Guidelines

Conflict of Interest

Dr. David A. Gudis declares that he has no conflict of interest. Dr. Zachary M. Soler reports personal fees from Olympus, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Rosenfeld RM, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152:S1–39.CrossRefPubMedGoogle Scholar
  2. 2.
    Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;. doi: 10.4193/Rhino12.000.Google Scholar
  3. 3.
    Desrosiers M, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol. 2011;7:2.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    • Banglawala SM, et al. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2014;4:986–94. Excellent systematic review of medical therapy outcomes for olfactory function in patients with chronic rhinosinusitis with polyposis. Google Scholar
  5. 5.
    Jiang R-S, et al. Olfactory function in patients with chronic rhinosinusitis before and after functional endoscopic sinus surgery. Am J Rhinol. 2008;22:445–8.CrossRefPubMedGoogle Scholar
  6. 6.
    • Soler ZM, Mace J, Smith TL. Symptom-based presentation of chronic rhinosinusitis and symptom-specific outcomes after endoscopic sinus surgery. Am J Rhinol. 2008;22:297–301. A thorough investigation into which symptoms of chronic rhinosinusitis improve and to what degree in response to surgical therapy. Google Scholar
  7. 7.
    Litvack JR, Fong K, Mace J, James KE, Smith TL. Predictors of olfactory dysfunction in patients with chronic rhinosinusitis. Laryngoscope. 2008;118:2225–30.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Dalton P. Olfaction and anosmia in rhinosinusitis. Curr Allergy Asthma Rep. 2004;4:230–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Yee KK, et al. Analysis of the olfactory mucosa in chronic rhinosinusitis. Ann N Y Acad Sci. 2009;1170:590–5.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Doty RL, Mishra A. Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope. 2001;111:409–23.CrossRefPubMedGoogle Scholar
  11. 11.
    Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110:1071–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Philpott CM, Boak D. The impact of olfactory disorders in the United kingdom. Chem Senses. 2014;39:711–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13(1):8.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Doty RL, Kamath V. The influences of age on olfaction: a review. Front Psychol. 2014;5:20.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Gopinath B, et al. Olfactory impairment in older adults is associated with poorer diet quality over 5 years. Eur J Nutr. 2015;. doi: 10.1007/s00394-015-0921-2.PubMedGoogle Scholar
  16. 16.
    Neuland C, Bitter T, Marschner H, Gudziol H, Guntinas-Lichius O. Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia. Laryngoscope. 2011;121:867–72.CrossRefPubMedGoogle Scholar
  17. 17.
    Brämerson A, Nordin S, Bende M. Clinical experience with patients with olfactory complaints, and their quality of life. Acta Otolaryngol. 2007;127:167–74.CrossRefPubMedGoogle Scholar
  18. 18.
    Alt JA, Mace JC, Buniel MCF, Soler ZM, Smith TL. Predictors of olfactory dysfunction in rhinosinusitis using the brief smell identification test. Laryngoscope. 2014;124:E259–66.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gupta D, Gulati A, Singh I, Tekur U. Endoscopic, radiological, and symptom correlation of olfactory dysfunction in pre- and postsurgical patients of chronic rhinosinusitis. Chem Senses. 2014;39:705–10.CrossRefPubMedGoogle Scholar
  20. 20.
    Soler ZM, et al. Volumetric computed tomography analysis of the olfactory cleft in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5:846–54.CrossRefPubMedGoogle Scholar
  21. 21.
    • Litvack JR, Mace JC, Smith TL. Olfactory function and disease severity in chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23:139–44. A concise investigation into the relationship between olfactory function and chronic rhinosinusitis disease severity. Google Scholar
  22. 22.
    • Litvack JR, Mace J, Smith TL. Does olfactory function improve after endoscopic sinus surgery? Otolaryngol Head Neck Surg. 2009;140:312–9. Perhaps the most definitive study to date investigating not only the response of olfactory function to surgical management for chronic rhinosinusitis, but the importance of preoperative olfactory function. Google Scholar
  23. 23.
    Mori E, et al. Risk factors for olfactory dysfunction in chronic rhinosinusitis. Auris Nasus Larynx. 2013;40:465–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Simopoulos E, et al. Olfaction-associated quality of life in chronic rhinosinusitis: adaptation and validation of an olfaction-specific questionnaire. Laryngoscope. 2012;122:1450–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Alobid I, et al. Oral and intranasal steroid treatments improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis. Rhinology. 2012;50:171–7.PubMedGoogle Scholar
  26. 26.
    Kroflic B, Coer A, Baudoin T, Kalogjera L. Topical furosemide versus oral steroid in preoperative management of nasal polyposis. Eur Arch Otorhinolaryngol. 2006;263:767–71.CrossRefPubMedGoogle Scholar
  27. 27.
    Alobid I, Benitez P, Pujols L, Maldonado M. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology. 2006;44(1):8.PubMedGoogle Scholar
  28. 28.
    Vaidyanathan S, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011;154:293–302.CrossRefPubMedGoogle Scholar
  29. 29.
    Benítez P, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006;116:770–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Hissaria P, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. Clin Otolaryngol. 2008;33:29.CrossRefGoogle Scholar
  31. 31.
    Hissaria P, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118:128–33.CrossRefPubMedGoogle Scholar
  32. 32.
    Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007;117:1–28.CrossRefPubMedGoogle Scholar
  33. 33.
    Van Zele T, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069–1076.e4.CrossRefPubMedGoogle Scholar
  34. 34.
    Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg. 1997;123:595–600.CrossRefPubMedGoogle Scholar
  35. 35.
    Tos M, et al. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. Am J Rhinol. 1998;12:183–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Jankowski R, et al. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg. 2001;127:447–52.CrossRefPubMedGoogle Scholar
  37. 37.
    Aukema A, Mulder P, Fokkens W. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005;115:1017–23.CrossRefPubMedGoogle Scholar
  38. 38.
    Small C, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol. 2005;116:1275–81.CrossRefPubMedGoogle Scholar
  39. 39.
    Stjärne P, Blomgren K, Cayé-Thomasen P, Salo S, Søderstrøm T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2006;126:606–12.CrossRefPubMedGoogle Scholar
  40. 40.
    Small CB, Stryszak P, Danzig M, Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. J Allergy Clin Immunol. 2008;121:928–32.CrossRefPubMedGoogle Scholar
  41. 41.
    Jankowski R, Klossek J-M, Attali V, Coste A, Serrano E. Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis. Allergy. 2009;64:944–50.CrossRefPubMedGoogle Scholar
  42. 42.
    Vlckova I, et al. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device. Rhinology. 2009;47:419–26.PubMedGoogle Scholar
  43. 43.
    Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci. 1995;20:26–30.CrossRefPubMedGoogle Scholar
  44. 44.
    Keith P, Nieminen J, Hollingworth K, Dolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy. 2000;30:1460–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Penttila M, Poulsen P, Hollingworth K, Holmstrom M. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 mug once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy. 2000;30:94–102.CrossRefPubMedGoogle Scholar
  46. 46.
    Landis BN. Ratings of overall olfactory function. Chem Senses. 2003;28:691–4.CrossRefPubMedGoogle Scholar
  47. 47.
    Alobid I, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124:50–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Videler WJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66:1457–68.CrossRefPubMedGoogle Scholar
  49. 49.
    Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116:189–93.CrossRefPubMedGoogle Scholar
  50. 50.
    Ebbens F, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118:1149–56.CrossRefPubMedGoogle Scholar
  51. 51.
    Pinto JM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinol J. 2010;48(3):318.CrossRefGoogle Scholar
  52. 52.
    Ling FTK, Kountakis SE. Important clinical symptoms in patients undergoing functional endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2007;117:1090–3.CrossRefPubMedGoogle Scholar
  53. 53.
    Ehnhage A, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy. 2009;64:762–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Saedi B, Sadeghi M, Yazdani N, Afshari A. Effectiveness of FESS in smell improvement of sinusitis patients. Indian J Otolaryngol Head Neck Surg. 2012;65:283–7.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Minovi A, Hummel T, Ural A, Draf W, Bockmuhl U. Predictors of the outcome of nasal surgery in terms of olfactory function. Eur Arch Otorhinolaryngol. 2008;265:57–61.CrossRefPubMedGoogle Scholar
  56. 56.
    Pade J, Hummel T. Olfactory function following nasal surgery. Laryngoscope. 2008;118:1260–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Kim DW, Kim J-Y, Kim S-W, Jeon S-Y. Postoperative olfactory results in chronic rhinosinusitis with nasal polyposis according to wound healing status. Clin Exp Otorhinolaryngol. 2013;6:146–51.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Chester AC, Antisdel JL, Sindwani R. Symptom-specific outcomes of endoscopic sinus surgery: a systematic review. Otolaryngol Head Neck Surg. 2009;140:633–9.CrossRefPubMedGoogle Scholar
  59. 59.
    DeConde AS, et al. Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol. 2014;4:725–33.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    DeConde AS, et al. Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management. Int Forum Allergy Rhinol. 2014;5:36–45.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Otolaryngology – Head and Neck Surgery, New York Presbyterian Hospital, Morgan Stanley Children’s HospitalColumbia University Medical CenterNew YorkUSA
  2. 2.Division of Rhinology and Sinus Surgery, Department of Otolaryngology – Head and Neck SurgeryMedical University of South CarolinaCharlestonUSA

Personalised recommendations